SCHEMBL5659653

SCHEMBL5659653

COC(=O)c1cc(OC)c(OC)c2oc(CC(C)(C)C)cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.50
PDE4B Q07343 2/20 0.50
PDE4C Q08493 2/20 0.50
PDE4D Q08499 2/20 0.50
KDM4E B2RXH2 8/20 0.46
POLB P06746 3/20 0.46
HSD17B10 Q99714 4/20 0.43
USP2 O75604 1/20 0.43
ALDH1A1 P00352 5/20 0.40
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA7 P43166 2/20 0.39
CA9 Q16790 2/20 0.39
CA13 Q8N1Q1 2/20 0.39
CA2 P00918 1/20 0.39
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
PKM P14618 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5658621 0.85 KDM4E (0.49) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL5655596 0.84 KDM4E (0.48) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL5656372 0.80 KDM4E (0.44) KDM4EPOLBHSD17B10USP2ALDH1A1
SCHEMBL5657180 0.80 KDM4E (0.46) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL5657720 0.79 KDM4E (0.46) PDE4BPDE4DKDM4EPOLBHSD17B10
SCHEMBL5655693 0.79 KDM4E (0.45) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL5657121 0.78 MEN1 (0.43) KDM4EPOLBHSD17B10USP2ALDH1A1
SCHEMBL5669321 0.77 KDM4E (0.49) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL5659515 0.77 KDM4E (0.41) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL5659101 0.77 SMN1; SMN2 (0.46) KDM4EPOLBHSD17B10USP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030130-B2 Benzofuran derivatives and their use as antibacterial agents ARPIDA AG (CH) 2006-04-18 US disclosed
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents EVOLVA SA (CH) 2004-02-19 US disclosed
EP-1307445-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Arpida AG, (CH) 2003-05-07 EP disclosed
WO-2002010157-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2002-02-07 WO disclosed
WO-2002010156-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2002-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents SBDS, BPTF, DCXR PDE4A 3310/4885PDE4B 3190/4885PDE4C 3381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.